Summary: ADC Fetal and Neonatal’s Associate Editor, Jonathan Davis, and the Edition Editor of the journal, Ben Stenson, discuss the highlights from the January 2023 issue. The Fantoms article: https://fn.bmj.com/content/108/1/1 Additional links: Helix trial: https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(21)00264-3/fulltext Premiloc study: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(16)00202-6/fulltext SToP BPD study: https://jamanetwork.com/journals/jama/fullarticle/2722773 Early amino acids in preterm infants and neurodisability at 2 years: https://www.nejm.org/doi/full/10.1056/NEJMoa2204886?query=recirc_curatedRelated_article Commentary on early amino acid study: https://www.nejm.org/doi/full/10.1056/NEJMe2212522 Commentary on steroids and risk modification: https://fn.bmj.com/content/103/6/F500 Neoprom metaanalysis - https://pubmed.ncbi.nlm.nih.gov/29872859/ Boost II trial - https://www.nejm.org/doi/full/10.1056/nejmoa1514212 <p>Please listen to our regular podcasts and subscribe in Apple Podcasts, Google Podcasts, Stitcher and Spotify to get episodes automatically downloaded to your phone and computer. And if you enjoy the podcast, please leave us a review at https://podcasts.apple.com/gb/podcast/adc-podcast/id333278832</p>
